We examine whether BYHWD mitigates cognitive impairment by reshaping gut microbiota and modulating the C/EBPβ/AEP axis, thereby offering mechanistic insights into microbiota‐targeted strategies for AD intervention. The gene discussed is LGMN; the disease is Alzheimer disease.